Bausch Health Companies (BHC) Assets Average (2010 - 2026)
Bausch Health Companies (BHC) reported Assets Average of $25.4 billion for Q1 2026, down 3.93% on a YoY basis from $26.5 billion in Q1 2025, and down 4.37% sequentially from $26.6 billion in Q4 2025.
Bausch Health Companies (BHC) Assets Average (2010 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 17 years of Assets Average data on file, last reported at $25.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 3.93% year-over-year to $25.4 billion; the trailing twelve-month figure through Mar 2026 stood at $25.4 billion (down 3.93% YoY), and the FY2025 full-year result was $26.4 billion, down 1.83% from the prior year.
- Assets Average eased to $25.4 billion in Q1 2026, from $26.6 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $29.1 billion in Q1 2022 to a low of $25.4 billion in Q1 2026.
- A 5-year average of $26.8 billion and a median of $26.6 billion in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slipped 12.28% in 2023 and advanced 6.13% in 2024, its largest moves.
- Tracing BHC's Assets Average over 5 years: stood at $26.0 billion in 2022, then rose by 4.67% to $27.2 billion in 2023, then retreated by 2.48% to $26.5 billion in 2024, then rose by 0.24% to $26.6 billion in 2025, then decreased by 4.37% to $25.4 billion in 2026.
- Business Quant data shows BHC's Assets Average at $25.4 billion in Q1 2026, $26.6 billion in Q4 2025, and $27.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 25.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.43 Bn |
| Dec 31, 2025 | 26.60 Bn |
| Sep 30, 2025 | 27.05 Bn |
| Jun 30, 2025 | 26.84 Bn |
| Mar 31, 2025 | 26.47 Bn |
| Dec 31, 2024 | 26.53 Bn |
| Sep 30, 2024 | 26.52 Bn |
| Jun 30, 2024 | 26.70 Bn |
| Mar 31, 2024 | 27.13 Bn |
| Dec 31, 2023 | 27.21 Bn |
| Sep 30, 2023 | 26.28 Bn |
| Jun 30, 2023 | 25.47 Bn |
| Mar 31, 2023 | 25.57 Bn |
| Dec 31, 2022 | 25.99 Bn |
| Sep 30, 2022 | 27.23 Bn |
| Jun 30, 2022 | 28.63 Bn |
| Mar 31, 2022 | 29.15 Bn |
| Dec 31, 2021 | 29.23 Bn |
| Sep 30, 2021 | 29.65 Bn |
| Jun 30, 2021 | 30.12 Bn |